Novo Nordisk made a surprise bid for Metsera to boost its weight-loss market lead, trading at just 12x 2026 EPS. Read why NVO ...
The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback